Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival

Accumulating evidence suggests the roles of glutamate metabotropic receptors (GRMs) in cancer, in addition to synaptic signalling. The present study assessed the associations of genetic variants in eight GRM genes with regard to risk and overall survival (OS) in 780 renal cell carcinoma (RCC) patien...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Huang, Chao‐Yuan, Hsueh, Yu‐Mei, Chen, Lih‐Chyang, Cheng, Wei‐Chung, Yu, Chia‐Cheng, Chen, Wei‐Jen, Lu, Te‐Ling, Lan, Kuo‐Jin, Lee, Cheng‐Hsueh, Huang, Shu‐Pin, Bao, Bo‐Ying
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2018
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308098/
https://ncbi.nlm.nih.gov/pubmed/30488581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1901
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia